VirusGEN® AAV Transfection Kits with RevIT™ AAV Enhancer
Supplier: Mirus Bio
MIR8000
MIR8006
MIR8007
MIR8008
MIR8080
77119-144EA
308.28
USD
77119-144
77119-146
77119-148
77119-150
77394-770
VirusGEN® AAV Transfection Kits with RevIT™ AAV Enhancer
Transfection Reagents
This novel enhancer is easily integrated into existing workflows, and it produces 2-4x higher titers across a range of serotypes, cellular growth media formulations, and transfection platforms. RevIT™ AAV Enhancer can further drive down upstream manufacturing costs by permitting the use of lower levels of plasmid DNA while maintaining high-quality titers. Continual improvements in both upstream and downstream AAV manufacturing processes will allow the next generation of gene therapies to reach a broader audience
- Designed to deliver a higher titer for any serotype, reagent, media, or cell line.
- 2-4X increase in AAV titer.
- >50% reduction in cost per dose.
- 2X doses produced per bioreactor run.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...